Table of Content

1 Study Coverage
1.1 IDH1 Antibody Product Introduction
1.2 Market by Type
1.2.1 Global IDH1 Antibody Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Monoclonal
1.2.3 Polyclonal
1.3 Market by Application
1.3.1 Global IDH1 Antibody Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Immunochemistry (IHC)
1.3.3 Immunofluorescence (IF)
1.3.4 Immunoprecipitation (IP)
1.3.5 Western Blot (WB)
1.3.6 ELISA
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global IDH1 Antibody Sales Estimates and Forecasts 2018-2033
2.2 Global IDH1 Antibody Revenue by Region
2.2.1 Global IDH1 Antibody Revenue by Region: 2018 VS 2022 VS 2033
2.2.2 Global IDH1 Antibody Revenue by Region (2018-2023)
2.2.3 Global IDH1 Antibody Revenue by Region (2024-2033)
2.2.4 Global IDH1 Antibody Revenue Market Share by Region (2018-2033)
2.3 Global IDH1 Antibody Sales Estimates and Forecasts 2018-2033
2.4 Global IDH1 Antibody Sales by Region
2.4.1 Global IDH1 Antibody Sales by Region: 2018 VS 2022 VS 2033
2.4.2 Global IDH1 Antibody Sales by Region (2018-2023)
2.4.3 Global IDH1 Antibody Sales by Region (2024-2033)
2.4.4 Global IDH1 Antibody Sales Market Share by Region (2018-2033)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global IDH1 Antibody Sales by Manufacturers
3.1.1 Global IDH1 Antibody Sales by Manufacturers (2018-2023)
3.1.2 Global IDH1 Antibody Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of IDH1 Antibody in 2022
3.2 Global IDH1 Antibody Revenue by Manufacturers
3.2.1 Global IDH1 Antibody Revenue by Manufacturers (2018-2023)
3.2.2 Global IDH1 Antibody Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by IDH1 Antibody Revenue in 2022
3.3 Global Key Players of IDH1 Antibody, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global IDH1 Antibody Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global IDH1 Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of IDH1 Antibody, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of IDH1 Antibody, Product Offered and Application
3.8 Global Key Manufacturers of IDH1 Antibody, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global IDH1 Antibody Sales by Type
4.1.1 Global IDH1 Antibody Historical Sales by Type (2018-2023)
4.1.2 Global IDH1 Antibody Forecasted Sales by Type (2024-2033)
4.1.3 Global IDH1 Antibody Sales Market Share by Type (2018-2033)
4.2 Global IDH1 Antibody Revenue by Type
4.2.1 Global IDH1 Antibody Historical Revenue by Type (2018-2023)
4.2.2 Global IDH1 Antibody Forecasted Revenue by Type (2024-2033)
4.2.3 Global IDH1 Antibody Revenue Market Share by Type (2018-2033)
4.3 Global IDH1 Antibody Price by Type
4.3.1 Global IDH1 Antibody Price by Type (2018-2023)
4.3.2 Global IDH1 Antibody Price Forecast by Type (2024-2033)
5 Market Size by Application
5.1 Global IDH1 Antibody Sales by Application
5.1.1 Global IDH1 Antibody Historical Sales by Application (2018-2023)
5.1.2 Global IDH1 Antibody Forecasted Sales by Application (2024-2033)
5.1.3 Global IDH1 Antibody Sales Market Share by Application (2018-2033)
5.2 Global IDH1 Antibody Revenue by Application
5.2.1 Global IDH1 Antibody Historical Revenue by Application (2018-2023)
5.2.2 Global IDH1 Antibody Forecasted Revenue by Application (2024-2033)
5.2.3 Global IDH1 Antibody Revenue Market Share by Application (2018-2033)
5.3 Global IDH1 Antibody Price by Application
5.3.1 Global IDH1 Antibody Price by Application (2018-2023)
5.3.2 Global IDH1 Antibody Price Forecast by Application (2024-2033)
6 US & Canada
6.1 US & Canada IDH1 Antibody Market Size by Type
6.1.1 US & Canada IDH1 Antibody Sales by Type (2018-2033)
6.1.2 US & Canada IDH1 Antibody Revenue by Type (2018-2033)
6.2 US & Canada IDH1 Antibody Market Size by Application
6.2.1 US & Canada IDH1 Antibody Sales by Application (2018-2033)
6.2.2 US & Canada IDH1 Antibody Revenue by Application (2018-2033)
6.3 US & Canada IDH1 Antibody Market Size by Country
6.3.1 US & Canada IDH1 Antibody Revenue by Country: 2018 VS 2022 VS 2033
6.3.2 US & Canada IDH1 Antibody Sales by Country (2018-2033)
6.3.3 US & Canada IDH1 Antibody Revenue by Country (2018-2033)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe IDH1 Antibody Market Size by Type
7.1.1 Europe IDH1 Antibody Sales by Type (2018-2033)
7.1.2 Europe IDH1 Antibody Revenue by Type (2018-2033)
7.2 Europe IDH1 Antibody Market Size by Application
7.2.1 Europe IDH1 Antibody Sales by Application (2018-2033)
7.2.2 Europe IDH1 Antibody Revenue by Application (2018-2033)
7.3 Europe IDH1 Antibody Market Size by Country
7.3.1 Europe IDH1 Antibody Revenue by Country: 2018 VS 2022 VS 2033
7.3.2 Europe IDH1 Antibody Sales by Country (2018-2033)
7.3.3 Europe IDH1 Antibody Revenue by Country (2018-2033)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China IDH1 Antibody Market Size
8.1.1 China IDH1 Antibody Sales (2018-2033)
8.1.2 China IDH1 Antibody Revenue (2018-2033)
8.2 China IDH1 Antibody Market Size by Application
8.2.1 China IDH1 Antibody Sales by Application (2018-2033)
8.2.2 China IDH1 Antibody Revenue by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia IDH1 Antibody Market Size by Type
9.1.1 Asia IDH1 Antibody Sales by Type (2018-2033)
9.1.2 Asia IDH1 Antibody Revenue by Type (2018-2033)
9.2 Asia IDH1 Antibody Market Size by Application
9.2.1 Asia IDH1 Antibody Sales by Application (2018-2033)
9.2.2 Asia IDH1 Antibody Revenue by Application (2018-2033)
9.3 Asia IDH1 Antibody Sales by Region
9.3.1 Asia IDH1 Antibody Revenue by Region: 2018 VS 2022 VS 2033
9.3.2 Asia IDH1 Antibody Revenue by Region (2018-2033)
9.3.3 Asia IDH1 Antibody Sales by Region (2018-2033)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America IDH1 Antibody Market Size by Type
10.1.1 Middle East, Africa and Latin America IDH1 Antibody Sales by Type (2018-2033)
10.1.2 Middle East, Africa and Latin America IDH1 Antibody Revenue by Type (2018-2033)
10.2 Middle East, Africa and Latin America IDH1 Antibody Market Size by Application
10.2.1 Middle East, Africa and Latin America IDH1 Antibody Sales by Application (2018-2033)
10.2.2 Middle East, Africa and Latin America IDH1 Antibody Revenue by Application (2018-2033)
10.3 Middle East, Africa and Latin America IDH1 Antibody Sales by Country
10.3.1 Middle East, Africa and Latin America IDH1 Antibody Revenue by Country: 2018 VS 2022 VS 2033
10.3.2 Middle East, Africa and Latin America IDH1 Antibody Revenue by Country (2018-2033)
10.3.3 Middle East, Africa and Latin America IDH1 Antibody Sales by Country (2018-2033)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Merck
11.1.1 Merck Company Information
11.1.2 Merck Overview
11.1.3 Merck IDH1 Antibody Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 Merck IDH1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Merck Recent Developments
11.2 GeneTex
11.2.1 GeneTex Company Information
11.2.2 GeneTex Overview
11.2.3 GeneTex IDH1 Antibody Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 GeneTex IDH1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 GeneTex Recent Developments
11.3 Abcam
11.3.1 Abcam Company Information
11.3.2 Abcam Overview
11.3.3 Abcam IDH1 Antibody Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 Abcam IDH1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Abcam Recent Developments
11.4 BosterBio
11.4.1 BosterBio Company Information
11.4.2 BosterBio Overview
11.4.3 BosterBio IDH1 Antibody Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 BosterBio IDH1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 BosterBio Recent Developments
11.5 Proteintech Group
11.5.1 Proteintech Group Company Information
11.5.2 Proteintech Group Overview
11.5.3 Proteintech Group IDH1 Antibody Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 Proteintech Group IDH1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Proteintech Group Recent Developments
11.6 Abnova Corporation
11.6.1 Abnova Corporation Company Information
11.6.2 Abnova Corporation Overview
11.6.3 Abnova Corporation IDH1 Antibody Sales, Price, Revenue and Gross Margin (2018-2023)
11.6.4 Abnova Corporation IDH1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Abnova Corporation Recent Developments
11.7 Novus Biologicals
11.7.1 Novus Biologicals Company Information
11.7.2 Novus Biologicals Overview
11.7.3 Novus Biologicals IDH1 Antibody Sales, Price, Revenue and Gross Margin (2018-2023)
11.7.4 Novus Biologicals IDH1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Novus Biologicals Recent Developments
11.8 NSJ Bioreagents
11.8.1 NSJ Bioreagents Company Information
11.8.2 NSJ Bioreagents Overview
11.8.3 NSJ Bioreagents IDH1 Antibody Sales, Price, Revenue and Gross Margin (2018-2023)
11.8.4 NSJ Bioreagents IDH1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 NSJ Bioreagents Recent Developments
11.9 LifeSpan BioSciences
11.9.1 LifeSpan BioSciences Company Information
11.9.2 LifeSpan BioSciences Overview
11.9.3 LifeSpan BioSciences IDH1 Antibody Sales, Price, Revenue and Gross Margin (2018-2023)
11.9.4 LifeSpan BioSciences IDH1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 LifeSpan BioSciences Recent Developments
11.10 Abeomics
11.10.1 Abeomics Company Information
11.10.2 Abeomics Overview
11.10.3 Abeomics IDH1 Antibody Sales, Price, Revenue and Gross Margin (2018-2023)
11.10.4 Abeomics IDH1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Abeomics Recent Developments
11.11 ProSci
11.11.1 ProSci Company Information
11.11.2 ProSci Overview
11.11.3 ProSci IDH1 Antibody Sales, Price, Revenue and Gross Margin (2018-2023)
11.11.4 ProSci IDH1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 ProSci Recent Developments
11.12 QED Bioscience
11.12.1 QED Bioscience Company Information
11.12.2 QED Bioscience Overview
11.12.3 QED Bioscience IDH1 Antibody Sales, Price, Revenue and Gross Margin (2018-2023)
11.12.4 QED Bioscience IDH1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 QED Bioscience Recent Developments
11.13 Cell Signaling Technology
11.13.1 Cell Signaling Technology Company Information
11.13.2 Cell Signaling Technology Overview
11.13.3 Cell Signaling Technology IDH1 Antibody Sales, Price, Revenue and Gross Margin (2018-2023)
11.13.4 Cell Signaling Technology IDH1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Cell Signaling Technology Recent Developments
11.14 RayBiotech
11.14.1 RayBiotech Company Information
11.14.2 RayBiotech Overview
11.14.3 RayBiotech IDH1 Antibody Sales, Price, Revenue and Gross Margin (2018-2023)
11.14.4 RayBiotech IDH1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 RayBiotech Recent Developments
11.15 EpiGentek
11.15.1 EpiGentek Company Information
11.15.2 EpiGentek Overview
11.15.3 EpiGentek IDH1 Antibody Sales, Price, Revenue and Gross Margin (2018-2023)
11.15.4 EpiGentek IDH1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 EpiGentek Recent Developments
11.16 Enzo Life Sciences
11.16.1 Enzo Life Sciences Company Information
11.16.2 Enzo Life Sciences Overview
11.16.3 Enzo Life Sciences IDH1 Antibody Sales, Price, Revenue and Gross Margin (2018-2023)
11.16.4 Enzo Life Sciences IDH1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Enzo Life Sciences Recent Developments
11.17 OriGene Technologies
11.17.1 OriGene Technologies Company Information
11.17.2 OriGene Technologies Overview
11.17.3 OriGene Technologies IDH1 Antibody Sales, Price, Revenue and Gross Margin (2018-2023)
11.17.4 OriGene Technologies IDH1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 OriGene Technologies Recent Developments
11.18 Jingjie PTM BioLab
11.18.1 Jingjie PTM BioLab Company Information
11.18.2 Jingjie PTM BioLab Overview
11.18.3 Jingjie PTM BioLab IDH1 Antibody Sales, Price, Revenue and Gross Margin (2018-2023)
11.18.4 Jingjie PTM BioLab IDH1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Jingjie PTM BioLab Recent Developments
11.19 Beijing Solarbio
11.19.1 Beijing Solarbio Company Information
11.19.2 Beijing Solarbio Overview
11.19.3 Beijing Solarbio IDH1 Antibody Sales, Price, Revenue and Gross Margin (2018-2023)
11.19.4 Beijing Solarbio IDH1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 Beijing Solarbio Recent Developments
11.20 Biobyt
11.20.1 Biobyt Company Information
11.20.2 Biobyt Overview
11.20.3 Biobyt IDH1 Antibody Sales, Price, Revenue and Gross Margin (2018-2023)
11.20.4 Biobyt IDH1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.20.5 Biobyt Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 IDH1 Antibody Industry Chain Analysis
12.2 IDH1 Antibody Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 IDH1 Antibody Production Mode & Process
12.4 IDH1 Antibody Sales and Marketing
12.4.1 IDH1 Antibody Sales Channels
12.4.2 IDH1 Antibody Distributors
12.5 IDH1 Antibody Customers
13 Market Dynamics
13.1 IDH1 Antibody Industry Trends
13.2 IDH1 Antibody Market Drivers
13.3 IDH1 Antibody Market Challenges
13.4 IDH1 Antibody Market Restraints
14 Key Findings in The Global IDH1 Antibody Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global IDH1 Antibody Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Table 2. Major Manufacturers of Monoclonal
Table 3. Major Manufacturers of Polyclonal
Table 4. Global IDH1 Antibody Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Table 5. Global IDH1 Antibody Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2033 (US$ Million)
Table 6. Global IDH1 Antibody Revenue by Region (2018-2023) & (US$ Million)
Table 7. Global IDH1 Antibody Revenue by Region (2024-2033) & (US$ Million)
Table 8. Global IDH1 Antibody Revenue Market Share by Region (2018-2023)
Table 9. Global IDH1 Antibody Revenue Market Share by Region (2024-2033)
Table 10. Global IDH1 Antibody Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2033 (US$ Million)
Table 11. Global IDH1 Antibody Sales by Region (2018-2023) & (ml)
Table 12. Global IDH1 Antibody Sales by Region (2024-2033) & (ml)
Table 13. Global IDH1 Antibody Sales Market Share by Region (2018-2023)
Table 14. Global IDH1 Antibody Sales Market Share by Region (2024-2033)
Table 15. Global IDH1 Antibody Sales by Manufacturers (2018-2023) & (ml)
Table 16. Global IDH1 Antibody Sales Share by Manufacturers (2018-2023)
Table 17. Global IDH1 Antibody Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 18. Global IDH1 Antibody Revenue Share by Manufacturers (2018-2023)
Table 19. Global Key Players of IDH1 Antibody, Industry Ranking, 2021 VS 2022 VS 2023
Table 20. IDH1 Antibody Price by Manufacturers 2018-2023 (US$/ml)
Table 21. Global IDH1 Antibody Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global IDH1 Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in IDH1 Antibody as of 2022)
Table 23. Global Key Manufacturers of IDH1 Antibody, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of IDH1 Antibody, Product Offered and Application
Table 25. Global Key Manufacturers of IDH1 Antibody, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global IDH1 Antibody Sales by Type (2018-2023) & (ml)
Table 28. Global IDH1 Antibody Sales by Type (2024-2033) & (ml)
Table 29. Global IDH1 Antibody Sales Share by Type (2018-2023)
Table 30. Global IDH1 Antibody Sales Share by Type (2024-2033)
Table 31. Global IDH1 Antibody Revenue by Type (2018-2023) & (US$ Million)
Table 32. Global IDH1 Antibody Revenue by Type (2024-2033) & (US$ Million)
Table 33. Global IDH1 Antibody Revenue Share by Type (2018-2023)
Table 34. Global IDH1 Antibody Revenue Share by Type (2024-2033)
Table 35. IDH1 Antibody Price by Type (2018-2023) & (US$/ml)
Table 36. Global IDH1 Antibody Price Forecast by Type (2024-2033) & (US$/ml)
Table 37. Global IDH1 Antibody Sales by Application (2018-2023) & (ml)
Table 38. Global IDH1 Antibody Sales by Application (2024-2033) & (ml)
Table 39. Global IDH1 Antibody Sales Share by Application (2018-2023)
Table 40. Global IDH1 Antibody Sales Share by Application (2024-2033)
Table 41. Global IDH1 Antibody Revenue by Application (2018-2023) & (US$ Million)
Table 42. Global IDH1 Antibody Revenue by Application (2024-2033) & (US$ Million)
Table 43. Global IDH1 Antibody Revenue Share by Application (2018-2023)
Table 44. Global IDH1 Antibody Revenue Share by Application (2024-2033)
Table 45. IDH1 Antibody Price by Application (2018-2023) & (US$/ml)
Table 46. Global IDH1 Antibody Price Forecast by Application (2024-2033) & (US$/ml)
Table 47. US & Canada IDH1 Antibody Sales by Type (2018-2023) & (ml)
Table 48. US & Canada IDH1 Antibody Sales by Type (2024-2033) & (ml)
Table 49. US & Canada IDH1 Antibody Revenue by Type (2018-2023) & (US$ Million)
Table 50. US & Canada IDH1 Antibody Revenue by Type (2024-2033) & (US$ Million)
Table 51. US & Canada IDH1 Antibody Sales by Application (2018-2023) & (ml)
Table 52. US & Canada IDH1 Antibody Sales by Application (2024-2033) & (ml)
Table 53. US & Canada IDH1 Antibody Revenue by Application (2018-2023) & (US$ Million)
Table 54. US & Canada IDH1 Antibody Revenue by Application (2024-2033) & (US$ Million)
Table 55. US & Canada IDH1 Antibody Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2033 (US$ Million)
Table 56. US & Canada IDH1 Antibody Revenue by Country (2018-2023) & (US$ Million)
Table 57. US & Canada IDH1 Antibody Revenue by Country (2024-2033) & (US$ Million)
Table 58. US & Canada IDH1 Antibody Sales by Country (2018-2023) & (ml)
Table 59. US & Canada IDH1 Antibody Sales by Country (2024-2033) & (ml)
Table 60. Europe IDH1 Antibody Sales by Type (2018-2023) & (ml)
Table 61. Europe IDH1 Antibody Sales by Type (2024-2033) & (ml)
Table 62. Europe IDH1 Antibody Revenue by Type (2018-2023) & (US$ Million)
Table 63. Europe IDH1 Antibody Revenue by Type (2024-2033) & (US$ Million)
Table 64. Europe IDH1 Antibody Sales by Application (2018-2023) & (ml)
Table 65. Europe IDH1 Antibody Sales by Application (2024-2033) & (ml)
Table 66. Europe IDH1 Antibody Revenue by Application (2018-2023) & (US$ Million)
Table 67. Europe IDH1 Antibody Revenue by Application (2024-2033) & (US$ Million)
Table 68. Europe IDH1 Antibody Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2033 (US$ Million)
Table 69. Europe IDH1 Antibody Revenue by Country (2018-2023) & (US$ Million)
Table 70. Europe IDH1 Antibody Revenue by Country (2024-2033) & (US$ Million)
Table 71. Europe IDH1 Antibody Sales by Country (2018-2023) & (ml)
Table 72. Europe IDH1 Antibody Sales by Country (2024-2033) & (ml)
Table 73. China IDH1 Antibody Sales by Type (2018-2023) & (ml)
Table 74. China IDH1 Antibody Sales by Type (2024-2033) & (ml)
Table 75. China IDH1 Antibody Revenue by Type (2018-2023) & (US$ Million)
Table 76. China IDH1 Antibody Revenue by Type (2024-2033) & (US$ Million)
Table 77. China IDH1 Antibody Sales by Application (2018-2023) & (ml)
Table 78. China IDH1 Antibody Sales by Application (2024-2033) & (ml)
Table 79. China IDH1 Antibody Revenue by Application (2018-2023) & (US$ Million)
Table 80. China IDH1 Antibody Revenue by Application (2024-2033) & (US$ Million)
Table 81. Asia IDH1 Antibody Sales by Type (2018-2023) & (ml)
Table 82. Asia IDH1 Antibody Sales by Type (2024-2033) & (ml)
Table 83. Asia IDH1 Antibody Revenue by Type (2018-2023) & (US$ Million)
Table 84. Asia IDH1 Antibody Revenue by Type (2024-2033) & (US$ Million)
Table 85. Asia IDH1 Antibody Sales by Application (2018-2023) & (ml)
Table 86. Asia IDH1 Antibody Sales by Application (2024-2033) & (ml)
Table 87. Asia IDH1 Antibody Revenue by Application (2018-2023) & (US$ Million)
Table 88. Asia IDH1 Antibody Revenue by Application (2024-2033) & (US$ Million)
Table 89. Asia IDH1 Antibody Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2033 (US$ Million)
Table 90. Asia IDH1 Antibody Revenue by Region (2018-2023) & (US$ Million)
Table 91. Asia IDH1 Antibody Revenue by Region (2024-2033) & (US$ Million)
Table 92. Asia IDH1 Antibody Sales by Region (2018-2023) & (ml)
Table 93. Asia IDH1 Antibody Sales by Region (2024-2033) & (ml)
Table 94. Middle East, Africa and Latin America IDH1 Antibody Sales by Type (2018-2023) & (ml)
Table 95. Middle East, Africa and Latin America IDH1 Antibody Sales by Type (2024-2033) & (ml)
Table 96. Middle East, Africa and Latin America IDH1 Antibody Revenue by Type (2018-2023) & (US$ Million)
Table 97. Middle East, Africa and Latin America IDH1 Antibody Revenue by Type (2024-2033) & (US$ Million)
Table 98. Middle East, Africa and Latin America IDH1 Antibody Sales by Application (2018-2023) & (ml)
Table 99. Middle East, Africa and Latin America IDH1 Antibody Sales by Application (2024-2033) & (ml)
Table 100. Middle East, Africa and Latin America IDH1 Antibody Revenue by Application (2018-2023) & (US$ Million)
Table 101. Middle East, Africa and Latin America IDH1 Antibody Revenue by Application (2024-2033) & (US$ Million)
Table 102. Middle East, Africa and Latin America IDH1 Antibody Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2033 (US$ Million)
Table 103. Middle East, Africa and Latin America IDH1 Antibody Revenue by Country (2018-2023) & (US$ Million)
Table 104. Middle East, Africa and Latin America IDH1 Antibody Revenue by Country (2024-2033) & (US$ Million)
Table 105. Middle East, Africa and Latin America IDH1 Antibody Sales by Country (2018-2023) & (ml)
Table 106. Middle East, Africa and Latin America IDH1 Antibody Sales by Country (2024-2033) & (ml)
Table 107. Merck Company Information
Table 108. Merck Description and Major Businesses
Table 109. Merck IDH1 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 110. Merck IDH1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Merck Recent Developments
Table 112. GeneTex Company Information
Table 113. GeneTex Description and Major Businesses
Table 114. GeneTex IDH1 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 115. GeneTex IDH1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. GeneTex Recent Developments
Table 117. Abcam Company Information
Table 118. Abcam Description and Major Businesses
Table 119. Abcam IDH1 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 120. Abcam IDH1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Abcam Recent Developments
Table 122. BosterBio Company Information
Table 123. BosterBio Description and Major Businesses
Table 124. BosterBio IDH1 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 125. BosterBio IDH1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. BosterBio Recent Developments
Table 127. Proteintech Group Company Information
Table 128. Proteintech Group Description and Major Businesses
Table 129. Proteintech Group IDH1 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 130. Proteintech Group IDH1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Proteintech Group Recent Developments
Table 132. Abnova Corporation Company Information
Table 133. Abnova Corporation Description and Major Businesses
Table 134. Abnova Corporation IDH1 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 135. Abnova Corporation IDH1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Abnova Corporation Recent Developments
Table 137. Novus Biologicals Company Information
Table 138. Novus Biologicals Description and Major Businesses
Table 139. Novus Biologicals IDH1 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 140. Novus Biologicals IDH1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Novus Biologicals Recent Developments
Table 142. NSJ Bioreagents Company Information
Table 143. NSJ Bioreagents Description and Major Businesses
Table 144. NSJ Bioreagents IDH1 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 145. NSJ Bioreagents IDH1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. NSJ Bioreagents Recent Developments
Table 147. LifeSpan BioSciences Company Information
Table 148. LifeSpan BioSciences Description and Major Businesses
Table 149. LifeSpan BioSciences IDH1 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 150. LifeSpan BioSciences IDH1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. LifeSpan BioSciences Recent Developments
Table 152. Abeomics Company Information
Table 153. Abeomics Description and Major Businesses
Table 154. Abeomics IDH1 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 155. Abeomics IDH1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Abeomics Recent Developments
Table 157. ProSci Company Information
Table 158. ProSci Description and Major Businesses
Table 159. ProSci IDH1 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 160. ProSci IDH1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. ProSci Recent Developments
Table 162. QED Bioscience Company Information
Table 163. QED Bioscience Description and Major Businesses
Table 164. QED Bioscience IDH1 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 165. QED Bioscience IDH1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. QED Bioscience Recent Developments
Table 167. Cell Signaling Technology Company Information
Table 168. Cell Signaling Technology Description and Major Businesses
Table 169. Cell Signaling Technology IDH1 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 170. Cell Signaling Technology IDH1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 171. Cell Signaling Technology Recent Developments
Table 172. RayBiotech Company Information
Table 173. RayBiotech Description and Major Businesses
Table 174. RayBiotech IDH1 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 175. RayBiotech IDH1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 176. RayBiotech Recent Developments
Table 177. EpiGentek Company Information
Table 178. EpiGentek Description and Major Businesses
Table 179. EpiGentek IDH1 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 180. EpiGentek IDH1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 181. EpiGentek Recent Developments
Table 182. Enzo Life Sciences Company Information
Table 183. Enzo Life Sciences Description and Major Businesses
Table 184. Enzo Life Sciences IDH1 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 185. Enzo Life Sciences IDH1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 186. Enzo Life Sciences Recent Developments
Table 187. OriGene Technologies Company Information
Table 188. OriGene Technologies Description and Major Businesses
Table 189. OriGene Technologies IDH1 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 190. OriGene Technologies IDH1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 191. OriGene Technologies Recent Developments
Table 192. Jingjie PTM BioLab Company Information
Table 193. Jingjie PTM BioLab Description and Major Businesses
Table 194. Jingjie PTM BioLab IDH1 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 195. Jingjie PTM BioLab IDH1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 196. Jingjie PTM BioLab Recent Developments
Table 197. Beijing Solarbio Company Information
Table 198. Beijing Solarbio Description and Major Businesses
Table 199. Beijing Solarbio IDH1 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 200. Beijing Solarbio IDH1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 201. Beijing Solarbio Recent Developments
Table 202. Biobyt Company Information
Table 203. Biobyt Description and Major Businesses
Table 204. Biobyt IDH1 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 205. Biobyt IDH1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
Table 206. Biobyt Recent Developments
Table 207. Key Raw Materials Lists
Table 208. Raw Materials Key Suppliers Lists
Table 209. IDH1 Antibody Distributors List
Table 210. IDH1 Antibody Customers List
Table 211. IDH1 Antibody Market Trends
Table 212. IDH1 Antibody Market Drivers
Table 213. IDH1 Antibody Market Challenges
Table 214. IDH1 Antibody Market Restraints
Table 215. Research Programs/Design for This Report
Table 216. Key Data Information from Secondary Sources
Table 217. Key Data Information from Primary Sources
List of Figures
Figure 1. IDH1 Antibody Product Picture
Figure 2. Global IDH1 Antibody Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 3. Global IDH1 Antibody Market Share by Type in 2022 & 2033
Figure 4. Monoclonal Product Picture
Figure 5. Polyclonal Product Picture
Figure 6. Global IDH1 Antibody Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 7. Global IDH1 Antibody Market Share by Application in 2022 & 2033
Figure 8. Immunochemistry (IHC)
Figure 9. Immunofluorescence (IF)
Figure 10. Immunoprecipitation (IP)
Figure 11. Western Blot (WB)
Figure 12. ELISA
Figure 13. Others
Figure 14. IDH1 Antibody Report Years Considered
Figure 15. Global IDH1 Antibody Revenue, (US$ Million), 2018 VS 2022 VS 2033
Figure 16. Global IDH1 Antibody Revenue 2018-2033 (US$ Million)
Figure 17. Global IDH1 Antibody Revenue Market Share by Region in Percentage: 2022 Versus 2033
Figure 18. Global IDH1 Antibody Revenue Market Share by Region (2018-2033)
Figure 19. Global IDH1 Antibody Sales 2018-2033 ((ml)
Figure 20. Global IDH1 Antibody Sales Market Share by Region (2018-2033)
Figure 21. US & Canada IDH1 Antibody Sales YoY (2018-2033) & (ml)
Figure 22. US & Canada IDH1 Antibody Revenue YoY (2018-2033) & (US$ Million)
Figure 23. Europe IDH1 Antibody Sales YoY (2018-2033) & (ml)
Figure 24. Europe IDH1 Antibody Revenue YoY (2018-2033) & (US$ Million)
Figure 25. China IDH1 Antibody Sales YoY (2018-2033) & (ml)
Figure 26. China IDH1 Antibody Revenue YoY (2018-2033) & (US$ Million)
Figure 27. Asia (excluding China) IDH1 Antibody Sales YoY (2018-2033) & (ml)
Figure 28. Asia (excluding China) IDH1 Antibody Revenue YoY (2018-2033) & (US$ Million)
Figure 29. Middle East, Africa and Latin America IDH1 Antibody Sales YoY (2018-2033) & (ml)
Figure 30. Middle East, Africa and Latin America IDH1 Antibody Revenue YoY (2018-2033) & (US$ Million)
Figure 31. The IDH1 Antibody Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 32. The Top 5 and 10 Largest Manufacturers of IDH1 Antibody in the World: Market Share by IDH1 Antibody Revenue in 2022
Figure 33. Global IDH1 Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 34. Global IDH1 Antibody Sales Market Share by Type (2018-2033)
Figure 35. Global IDH1 Antibody Revenue Market Share by Type (2018-2033)
Figure 36. Global IDH1 Antibody Sales Market Share by Application (2018-2033)
Figure 37. Global IDH1 Antibody Revenue Market Share by Application (2018-2033)
Figure 38. US & Canada IDH1 Antibody Sales Market Share by Type (2018-2033)
Figure 39. US & Canada IDH1 Antibody Revenue Market Share by Type (2018-2033)
Figure 40. US & Canada IDH1 Antibody Sales Market Share by Application (2018-2033)
Figure 41. US & Canada IDH1 Antibody Revenue Market Share by Application (2018-2033)
Figure 42. US & Canada IDH1 Antibody Revenue Share by Country (2018-2033)
Figure 43. US & Canada IDH1 Antibody Sales Share by Country (2018-2033)
Figure 44. U.S. IDH1 Antibody Revenue (2018-2033) & (US$ Million)
Figure 45. Canada IDH1 Antibody Revenue (2018-2033) & (US$ Million)
Figure 46. Europe IDH1 Antibody Sales Market Share by Type (2018-2033)
Figure 47. Europe IDH1 Antibody Revenue Market Share by Type (2018-2033)
Figure 48. Europe IDH1 Antibody Sales Market Share by Application (2018-2033)
Figure 49. Europe IDH1 Antibody Revenue Market Share by Application (2018-2033)
Figure 50. Europe IDH1 Antibody Revenue Share by Country (2018-2033)
Figure 51. Europe IDH1 Antibody Sales Share by Country (2018-2033)
Figure 52. Germany IDH1 Antibody Revenue (2018-2033) & (US$ Million)
Figure 53. France IDH1 Antibody Revenue (2018-2033) & (US$ Million)
Figure 54. U.K. IDH1 Antibody Revenue (2018-2033) & (US$ Million)
Figure 55. Italy IDH1 Antibody Revenue (2018-2033) & (US$ Million)
Figure 56. Russia IDH1 Antibody Revenue (2018-2033) & (US$ Million)
Figure 57. China IDH1 Antibody Sales Market Share by Type (2018-2033)
Figure 58. China IDH1 Antibody Revenue Market Share by Type (2018-2033)
Figure 59. China IDH1 Antibody Sales Market Share by Application (2018-2033)
Figure 60. China IDH1 Antibody Revenue Market Share by Application (2018-2033)
Figure 61. Asia IDH1 Antibody Sales Market Share by Type (2018-2033)
Figure 62. Asia IDH1 Antibody Revenue Market Share by Type (2018-2033)
Figure 63. Asia IDH1 Antibody Sales Market Share by Application (2018-2033)
Figure 64. Asia IDH1 Antibody Revenue Market Share by Application (2018-2033)
Figure 65. Asia IDH1 Antibody Revenue Share by Region (2018-2033)
Figure 66. Asia IDH1 Antibody Sales Share by Region (2018-2033)
Figure 67. Japan IDH1 Antibody Revenue (2018-2033) & (US$ Million)
Figure 68. South Korea IDH1 Antibody Revenue (2018-2033) & (US$ Million)
Figure 69. China Taiwan IDH1 Antibody Revenue (2018-2033) & (US$ Million)
Figure 70. Southeast Asia IDH1 Antibody Revenue (2018-2033) & (US$ Million)
Figure 71. India IDH1 Antibody Revenue (2018-2033) & (US$ Million)
Figure 72. Middle East, Africa and Latin America IDH1 Antibody Sales Market Share by Type (2018-2033)
Figure 73. Middle East, Africa and Latin America IDH1 Antibody Revenue Market Share by Type (2018-2033)
Figure 74. Middle East, Africa and Latin America IDH1 Antibody Sales Market Share by Application (2018-2033)
Figure 75. Middle East, Africa and Latin America IDH1 Antibody Revenue Market Share by Application (2018-2033)
Figure 76. Middle East, Africa and Latin America IDH1 Antibody Revenue Share by Country (2018-2033)
Figure 77. Middle East, Africa and Latin America IDH1 Antibody Sales Share by Country (2018-2033)
Figure 78. Brazil IDH1 Antibody Revenue (2018-2033) & (US$ Million)
Figure 79. Mexico IDH1 Antibody Revenue (2018-2033) & (US$ Million)
Figure 80. Turkey IDH1 Antibody Revenue (2018-2033) & (US$ Million)
Figure 81. Israel IDH1 Antibody Revenue (2018-2033) & (US$ Million)
Figure 82. GCC Countries IDH1 Antibody Revenue (2018-2033) & (US$ Million)
Figure 83. IDH1 Antibody Value Chain
Figure 84. IDH1 Antibody Production Process
Figure 85. Channels of Distribution
Figure 86. Distributors Profiles
Figure 87. Bottom-up and Top-down Approaches for This Report
Figure 88. Data Triangulation
Figure 89. Key Executives Interviewed